|
Date : 11th May, 2009
Venue : The Doubletree Hotel San Diego Downtown, San Diego, California
|
The TriMark Point
of Care Testing Conference 2009 has been organized to provide a
critical examination of the point of care industry, as well as
valuable insights from key industry leaders concerning new cutting
edge point of care technologies, and the impact on clinical
medicine. This conference will also provide a forum for leaders in
point of care technology sector, point of care coordinators,
laboratory directors and clinical laboratorians to share ideas,
network with other delegates and advance understanding of the
potential of new point of care technologies for improving medical
care delivery. Attendees will receive 5.5 hours of continuing
education units (CEUs). The AACC's ACCENT credits are for
laboratory professionals who need to document their continuing
education to meet requirements for licensure or certification.
|
.gif) |
The Conference's
keynote speaker is :
 |
James H. Nichols, Ph.D., DABCC,
FACB
Dr. Nichols is an Associate
Professor of Pathology at Tufts University School of Medicine
and Director, Clinical Chemistry for Baystate Health in
Springfield, MA. Dr. Nichols received his B.A. in General
Biology/Pre-medicine from Revelle College, University of
California at San Diego. He went on to complete a Masters and
Doctorate in Biochemistry from the University of Illinois,
Urbana-Champaign. Dr. Nichols was a fellow in the Postdoctoral
Training Program in Clinical Chemistry at the Mayo Clinic,
Rochester, MN. He is board certified in both Clinical Chemistry
and Toxicological Chemistry by the American Board of Clinical
Chemistry. Dr. Nichols spent several years as Associate Director
of Clinical Chemistry, Director of Point-of-Care Testing, and an
Associate Professor of Pathology at Johns Hopkins Medical
Institutions prior to moving to Massachusetts. Baystate Health
includes Franklin Medical Center, Mary Lane Hospital and
Baystate Medical Center, a leading acute care center in New
England. Dr. Nichols is responsible for Clinical Chemistry
including core automated chemistry, immunoassay, endocrinology,
toxicology/therapeutic drug analysis, esoteric and point of care
testing conducted through Baystate Reference Laboratories, one
of America’s largest hospital-based outreach programs. Dr.
Nichols’ research interests span evidence-based medicine,
information management, laboratory automation, point-of-care
testing and toxicology. |
Who Should Attend :
- Point of care coordinators.
- Medical technologists and
laboratorians.
- Laboratory directors and
supervisors.
- Point of care technology
development companies.
- Physicians and clinical
scientists.
- Industry representatives and
researchers.
- Regulatory personnel.
Leaders from the Following Areas
Will Greatly Benefit from Attending :
- Laboratory leaders.
- Hospital CFOs and CSOs.
- Point of care and in vitro
diagnostic companies.
- Business development.
- Strategic planning and
development.
- Technology development.
- Marketing.
- Research and development.
Key Themes :
- A critical examination of key
emerging technologies in to point of care testing.
- Transitioning from laboratory in
vitro diagnostics to point of care diagnostics.
- Evidence based medicine at the
point of care testing.
- Point of care testing as an
essential critical care medicine tool.
- Point of care testing is an
important resource tool for practicing family medicine.
Issues Addressed at the TriMark
Conference :
- How to achieve quality in point of
care testing.
- How to implement point of care
testing to improve patient outcomes.
- The impact of molecular
diagnostics on point of care testing.
- Which new technologies will reach
the point of care market in the next 2-3 years?
- Point of care testing in rapid
diagnosis of AMI in the ED.
- What are the prospects for point
of care testing in the future?
- How is technology innovation
facilitating the transition of POC testing into standard healthcare
practice?
Top Five Reasons To Attend the
TriMark Conference :
- Discover the point of care sectors
with the greatest impact on patient care.
- Identify the key players in the
point of care market and recognize how their technology platforms
can energize point of care testing.
- Understand the factors driving
growth of the point of care market, which represents over 30% of
global in vitro diagnostics sales.
- Discover the future of point of
care testing.
- See the top innovators in point of
care testing technology.
Registration Fees for the
Conference :
|
Early-Bird Registration Fee (until
April 30, 2009) |
US$295 |
|
Standard Registration Fee (on and
after May 1, 2009) |
US$395 |
|
At-the-Door Fee (on May 11, 2009 -
subject to seating availability) |
US$595 |
|
Click here to register online now |
Schedule:
- Registration at 8:00 am.
- Lunch at 12:30 pm.
- Cocktails/networking at 5:30 pm.
Agenda :
8:00 am – 9:00 am
Registration and Continental Breakfast
9:00 am – 9:10 am
Welcoming and Introductory Remarks
Joseph Dooley, Ph.D., DABCC, FACB, Editor-in-Chief, TriMark
Publications, LLC
9:10 am – 10:00 am
Keynote Speaker – Achieving Quality at the POCT: Changes that are
Moving Towards a Risk Management Approach in the ISO and CLIS
Standards
James Nichols, Ph.D., DABCC, FACB,
Associate Professor of Pathology at
Tufts University School of Medicine; Director of Clinical Chemistry
for Baystate Health in Springfield, MA
10:00 am – 10:30 am Intermission – Coffee and Meet the Exhibitors
10:30 am – 11:00 am The Evolution of Multianalyte Rapid Testing:
Nanogen’s Nexus Dx Rapid Testing System
Richard Egan, Ph.D., Executive Director, Immunoassay Development
Nanogen, Inc.
11:00 am – 11:45 am Implementing Point of Care Testing to Improve
Patient Outcomes in the Emergency Department
Kent Lewandrowski, M.D., Ph.D., Associate Chief of Pathology and
Director of Clinical Services, Massachusetts General Hospital;
Associate Professor at Harvard Medical School; Editor-in-Chief: Point
of Care: The Journal of Near Patient Testing Technologies
11:45 am – 12:15 pm Moving Molecular Diagnostics Closer to Patient
Care
Emily S. Winn-Deen, Ph.D., Vice President, Genetics and Oncology R&D,
Cepheid
12:15 pm – 12:30
pm Visit the Exhibits
12:30 pm – 1:30 pm Lunch
1:30 pm – 2:00 pm Efficacy of a Multi-Marker, Serial Draw Protocol
for the Rapid Diagnosis of AMI in the ED
Howard J. Kirchick, Ph.D., Scientific Affairs Director, Biosite, Inc.
2:00 pm – 2:30 pm POCT Glucose - How Do We Measure Up, What
Standards Apply & Where Are We Headed?
Jeff DuBois, Vice President, Medical & Scientific Affairs, Nova
Biomedical
2:30 pm – 2:45 pm Intermission
2:45 pm – 3:00 pm Business Changes in the Point of Care Testing
Sector: What’s Happening and Why
Joseph Dooley, Ph.D., DABCC, FACB, Editor-in-Chief, TriMark
Publications, LLC
3:00 pm – 3:30 pm
Recent Developments in Point of Care Testing for HIV and Hepatitis
Stephen R. Lee, Ph.D., Executive VP and CSO, OraSure Technologies
3:30 pm – 4:00 pm Point of Care Testing for Respiratory Pathogens:
Clinical Evidence Supporting Improved Patient Care
Aleta B. Bonner, MD, MSPH, FAAP, Clinical Assistant Professor,
Pediatric Emergency Medicine, Dell Children's Medical Center of
Central Texas
4:00 pm – 4:30 pm
Point of Care Testing in the Future
Barbara Goldsmith, Ph.D., DABCC, FACB, President, American Association
for Clinical Chemistry
4:30 pm – 5:30 pm
Conference Sponsors' Vendor Presentations
-
Roche.
-
Biosite.
-
Nova Biomedical.
-
Nanogen.
-
Quidel.
5:30 pm – 6:00 pm
Wine and Cheese |